ERBB2 and breast cancer: The L-type amino acid transporter 1 (LAT1) was found to promote chemoresistance in ER-positive/HER2-negative breast cancer [69] by facilitating the uptake of other amino acids, which can be used by cells for energy production and biomass synthesis, supporting the growth of cancer cells.